CSIMarket
 
Innovus Pharmaceuticals, Inc.  (INNV)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

Innovus Pharmaceuticals Growth Comparisons

Select each growth Category to receive further Information



INNV Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -22.02 % 5.65 % 7.64 % 7.81 %
Q / Q Revenue Growth (Q3 MRQ) -15.96 % 1.95 % 0.88 % 1.22 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 5.1 % 3.26 % 7.93 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -6.68 % 1.41 % 1.15 % 1.56 %
Revenue 5 Year Average Growth 414.71 % 12 % 10.85 % 9.45 %
Expected Revenue Growth (Y/Y) - - 1.89 % 3.04 %


INNV's Growth Comparisons in III. Quarter 2019




Innovus Pharmaceuticals's sharp decrease of -22.02% in sales in the third quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Biotechnology & Drugs industry with 5.65%, and underperformed the 7.64% Revenue growth in the Healthcare sector. Weak third quarter sales, in Biotechnology & Drugs industry and within the Healthcare sector, were reflected in Innovus Pharmaceuticals, Inc. results which underperformed overall market.

Comparing company's Revenue to the second quarter results, sales were lower by -15.96% . On the annual basis, average annual sales growth for Innovus Pharmaceuticals is 414.71%, while S & P 500's including only Businesses with the third quarter 2019 2019 Results, average yearly sales growth is 9.45% over the past five years.


Growth Rates of INNV's Income in the third quarter 2019


INNV Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - - 58.11 % 24.24 %
Seq. Operating Income Change (Q3 MRQ) - - -21.05 % -12.15 %
Y / Y Operating Income Growth (Q3 TTM) - - -48.68 % -8.86 %
Seq. Operating Income Growth (Q3 TTM) - - 37.65 % 1.32 %
Operating Income 5 Year Avg. Change - -3.73 % 1.71 % 13.15 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - - -39.42 % -7.68 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - - -46.01 % -10.29 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - - 126.3 % 14.21 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - - -10.42 % -1.21 %
Income from Cont. Ops. 5 Year Avg. Change - -6.1 % 8.02 % 33.18 %

INNV Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - - -40.13 % -10.79 %
Q / Q Net Income Growth (Q3 MRQ) - - -46.44 % -14.3 %
Y / Y Net Income Change (Q3 TTM) - - 143.24 % 14.19 %
Seq. Net Income Change (Q3 TTM) - - -10.63 % -1.28 %
Net Income 5 Year Avg. Growth - -5.16 % 1.92 % 32.48 %

INNV's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - - -39.42 % -7.68 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - - -46.01 % -10.29 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -4.85 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.29 % 8.02 % 33.18 %



INNV EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - - -40.13 % -10.79 %
Q / Q EPS Net Growth (Q3 MRQ) - - -46.44 % -14.3 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 66.02 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -2.01 %
EPS Net 5 Year Avg. Change - -5.16 % 1.92 % 32.48 %
Expected EPS Growth (Y/Y) - - 123.59 % 31.27 %



Innovus Pharmaceuticals reported bottom-line of $ -0.81 in the third quarter, compare to $ -0.01 in the same quarter a year ago. Biotechnology & Drugs industry grew by 5.65%, while Healthcare sector decreased by -40.13%, and overall market declined by -10.79%.

Comparing company's EPS to the second quarter results, income per share were lower by -15.96% . On the annual basis, average annual income per share growth for Innovus Pharmaceuticals is 414.71%, while S & P 500's including only Businesses with the third quarter 2019 financial reports, average yearly income per share growth is 32.48% over the past five years.

INNV Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 51.27 % 16.95 % -20.39 %
Seq. Free Cash Flow Change (Q3 MRQ) - 11953.61 % 106.28 % 8.24 %
Y / Y Free Cash Flow Change (Q3 TTM) - -16.45 % -0.36 % -9.41 %
Seq. Free Cash Flow Change (Q3 TTM) - 18.54 % 7.65 % -2.44 %
Free Cash Flow 5 Year Avg. Change - 19.63 % 9.23 % 31.81 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 285.29 % 226.8 % 394.98 %
Seq. Net Cash Flow Change (Q3 MRQ) - - -26.59 % 3695.15 %
Y / Y Net Cash Flow Change (Q3 TTM) - 47.26 % - -44.25 %
Seq. Net Cash Flow Change (Q3 TTM) - - 71.06 % -
Net Cash Flow 5 Year Avg. Change - 16.48 % 42.74 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -87.87 % 165.78 % 27.9 % 0.22 %
Seq. Capital Expenditures Change (Q3 MRQ) -68.75 % - 305.07 % 4.76 %
Y / Y Capital Expenditures Change (Q3 TTM) 102.28 % -8.93 % 1.12 % 2.02 %
Seq. Capital Expenditures Change (Q3 TTM) -7.84 % 11.01 % 9.59 % 2.69 %
Capital Expenditures 5 Year Avg. Change - 26.14 % 20.85 % 13.77 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OPGNW's Profile

Stock Price

OPGNW's Financials

Business Description

Fundamentals

Charts & Quotes

OPGNW's News

Suppliers

OPGNW's Competitors

Customers & Markets

Economic Indicators

OPGNW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071